Greg Guenthner

Biotech buyouts are coming. But no one’s paying attention…

New record highs for stocks are instead sparking refreshed arguments from economists and analysts alike. They want to debate peak valuations or whether or not we’re entering a “Goldilocks economy” where growth is not too hot, not too cold—but just right.

But all of the debate about how hot the economy will run for the rest of the year is distracting you from a couple of critical developments in the stock market.

The first (and potentially most important) trend you need to watch is the biotech comeback.

You know the drill…

Earlier this year, biotechs rocketed higher. The sector posted 30%-plus gains during the first eight weeks of the year. Almost every single day, a different biotech would easily rise double-digits. And while this was an active trader’s paradise, these stocks did end up getting a little ahead of themselves.

But now, we’re seeing a strong resurgence in the biotechs. In just a few weeks, these stocks have gone from losers back to winners. As of this morning, the biotech sector is up more than 12% on the year, compared to gains of just 5.5% in the S&P 500…

SPDR S&P Biotech Index vs. S&P 500

Now, the buyouts are back. Yesterday, a small-cap biotech called Idenix Pharmaceuticals (NASDAQ:IDIX) jumped by 229%. ‬

Yes, in one day…‬

How did this happen?

Well, pharmaceutical giant Merck agreed to pay $3.8 billion to acquire the company in full. Not only did Idenix stock shoot way up– almost every small to mid-size biotech stock went up because of the Merck – Idenix acquisition news.

Regards,

Greg Guenthner
for The Daily Reckoning

P.S. According to our own biotech expert Paul Mampilly, we should see more market-moving activity like this in the near future. I’ll be giving readers of my Rude Awakening email edition all the details – including regular chances at real, actionable profit opportunities – as the story progresses. So make sure you sign up for the Rude Awakening for FREE today to see how you can trade these trends for huge gains…

Greg Guenthner

Greg Guenthner, CMT, is the managing editor of The Rude Awakening. Greg is a member of the Market Technicians Association and holds the Chartered Market Technician designation.

Recent Articles

NATO Meeting Gives You a Strong “Buy” Signal

Byron King

In early September, 2014 an important meeting was held at the posh Celtic Manor, in Newport, Wales. Heads of state were present. But it was the appearance of a Lockheed F-35B fighter jet that held the real story of what was going on... Today, Byron King pulls back the curtain on this meeting, and how you can use it to your advantage in the market. Read on...


What to Do When the Largest IPO in History Hits the Market

Josh Grasmick

The largest IPO in history is about to hit the market. And there's all kinds of speculation as to how it's going to pan out. Today, Josh Grasmick gives a definitive answer... and offers some advice on how to play this new stock for huge gains no matter what happens on day one of the IPO. Read on...


Laissez Faire
One Great Tip for Investing in 3-D Imaging Technology

Chris Campbell

By now you're likely familiar with 3-D printing. It's one of the most important tech developments of the last decade, and it's just getting started. But as Chris Campbell explains, there's another form of 3-D technology that could soon overshadow it. Read on...


A Unique Way to Play the Health Craze

Greg Guenthner

With the rise of the organic food market, people are becoming more and more health conscious, and thus, more aware of what goes into cultivating their food. But there's one aspect of this market that's long overdue for a massive overhaul, and that could present a very lucrative investment opportunity. Greg Guenthner explains...


How to Invest in a Strong Dollar World

Chris Mayer

Our friend Jim Rickards and founder Addison Wiggin believe the dollar will soon meet its demise. Chris Mayer, on the other hand, thinks the dollar will only get stronger this year and next. We'll let you decide for yourself. In this featured essay Chris lays out his train of thought and a guide for investing in a strong dollar world. Read on...